# Kyberlife Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kyberlife-pte

- Industry: Retail
- Headquarters: Singapore, Singapore
- Website: www.kyberlife.com
- Total disclosed funding: $1.1M
- Latest round: Seed (Mar 17, 2023)
- Investors on record: 3

## About

Founded in 2020 and based in Singapore, Kyberlife Pte. Ltd. operates as a global platform for healthcare suppliers, life-science businesses, and manufacturers. In March 2022, Kyberlife Pte. Ltd. raised an undisclosed amount in venture funding led by PE Global including Amatar Investment and Rapzo Capital. In March 2025, Kyberlife Pte. Ltd. raised MYR 13.3 million in venture funding led by new investor 5I VENTURES PTE. LTD., with participation from other new investors East Ventures, A2D Ventures Pte. Ltd., and NUS Alumni Ventures. Ryan James Lim (CEO), Michael Tillmann (Chairman), and Wesley Lim (China Channel Lead) are the co-founders of the company. The company's products include consumables, microbiology, proteomics, medical devices, and diagnostics, biochemicals and diagnostics, animal care products, crop protection, formulation development and manufacturing, and more. The firm provides its products and services in life science, in vitro diagnostic, chemistry, consumer health, animal science, biopharmaceuticals, environment, and agriculture industries. Kyberlife's brands include BabyPass, Creative Biogene, Flowflex, GeneDireX, Inc., ONILAB, Sigma-Aldrich, The Kare Lab, and many others. The organization plans to use the March 2025 funds to expand in new regions, onboard additional suppliers, and invest in artificial intelligence to enhance procurement.

## Funding rounds

- Seed, Mar 17, 2023, $0.5M — PE Global
- Seed, Mar 8, 2022, $0.7M — Rapzo Capital, PE Global, Amatar Investment

## Investors

- Rapzo Capital — Seed
- PE Global (https://capitalatlas.ai/funds/pe-global) — Seed
- Amatar Investment — Seed